UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
‘Pfizer’s Vyndaqel, Vyndamax do not deserve rare disease pricing’
Pfizer’s Vyndaqel and Vyndamax -- containing tafamidis to treat cardiomyopa...
by Kim Yun-mi
|
2020-06-22 17:19
라인
Yonsei University Health System shares Covid-19 treatment knowledge
Yonsei University Health System (YUHS) and Korea International Cooperation ...
by Lee Han-soo
|
2020-06-22 14:33
라인
[Special] ‘Korea will be short of doctors even with more medical school admissions’
The nation is likely to be short of physicians until 2067 even if the gover...
by Song Soo-youn
|
2020-06-22 14:31
라인
New virus cases sank below 20 for 1st time in June
Korea’s new Covid-19 cases dipped below 20 on Sunday for the first time thi...
by Lee Han-soo
|
2020-06-22 11:55
라인
Keytruda-chemo treatment improves lung cancer patients’ survival
A Yonsei Cancer Center research team has confirmed that the combination the...
by Shim Hyun-tai
|
2020-06-19 19:05
라인
Childbirth, marriage continue to hit new lows in Korea
The number of childbirths and marriages hit new lows in 2019, despite the g...
by Lee Han-soo
|
2020-06-19 17:44
라인
Korean health insurance system to be promoted through World Bank
The National Health Insurance Service (NHIS) said it would team up with the...
by Kim Eun-young
|
2020-06-19 16:11
라인
Researchers develop nanotherapy targeting brain tumor
Local researchers said they have developed a new nanotherapy that targets a...
by Kim Eun-young
|
2020-06-19 16:02
라인
New diabetes drug Steglatro fails to prove cardiovascular benefit
Steglatro (ingredient: ertugliflozin), the latecomer sodium-glucose co-tran...
by Kim Yun-mi
|
2020-06-19 14:55
라인
Yuyu to export SD Biosensor's Covid-19 test kit
Yuyu Pharmaceutical and SD Biosensor said they would cooperate in exporting...
by Lee Han-soo
|
2020-06-19 14:48
라인
Covid-19 fight drags on amid risks of 2nd viral wave
Korea's combat against the coronavirus pandemic is turning into a long-...
by Lee Han-soo
|
2020-06-19 12:42
라인
‘Covid-19 may be last straw that broke inter-Korean camel’s back’
Amid rampant speculations about what drove North Korea to sever ties with t...
by Shim Hyun-tai
|
2020-06-18 18:22
라인
GC got Japanese patent for NK cell-culture tech
GC LabCell said Thursday that it has acquired a patent for culturing method...
by Shim Hyun-tai
|
2020-06-18 17:53
라인
HK inno.N nabs FDA nod for trial of gastric acid blocker
HK inno.N, formerly known as CJ Healthcare, said that the U.S. Food and Dru...
by Lee Han-soo
|
2020-06-18 17:39
라인
AZ’s Imfinzi wins extra indication for small-cell lung cancer
AstraZeneca’s immunotherapy Imfinzi (ingredient: durvalumab) has obtained l...
by Kim Yun-mi
|
2020-06-18 15:55
라인
5 key factors in successful secondary packaging and device assembly strategy
In his book The 7 Habits of Highly Effective People, Dr. Steven R. Covey of...
by Lee Han-soo
|
2020-06-18 15:52
라인
[Analysis] Revocation of Medytox license tolls death knell for once-promising biotech firm
Shares of Medytox nosedived Thursday after the Ministry of Food and Drug Sa...
by Lee Han-soo
|
2020-06-18 15:52
라인
Lilly beats Pfizer in treating early breast cancer
Pfizer was the first to release a drug for the treatment of hormone recepto...
by Kim Yun-mi
|
2020-06-18 14:44
라인
‘Tecentriq, major turning point for triple-negative breast cancer treatment’
Roche Korea’s Tecentriq, the first immunotherapy to win indication for trip...
by Kim Yun-mi
|
2020-06-18 14:43
라인
New virus cases near 60 as cluster infections go south
Korea’s new Covid-19 cases rose to the highest level in three weeks on Thur...
by Shim Hyun-tai
|
2020-06-18 14:24
-
이전
21
22
23
24
25
26
27
28
29
30
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top